ReviewCurrent pharmaceutical design2013
From bortezomib to other inhibitors of the proteasome and beyond.
Daniela Buac et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
67 papers cite itlatest 60 shown
this paperpooled itcites it